NCT03644225
- Conditions
- Connective Tissue Diseases, Scleroderma, Systemic, Skin Diseases, +2 more
- Locations
-
- Department of Rheumatology, University Hospital Zurich Zurich, Switzerland
Clinical trial condition
Scleroderma, Systemic
Explore clinical trials studying Scleroderma, Systemic. Study availability and eligibility vary by location and protocol.
433 public trials
125 recruiting studies
Scleroderma, Systemic trial results
NCT00114530
- Conditions
- Autoimmune Disease, Autoimmune Diseases, Connective Tissue Diseases, +7 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- UCLA Medical School Los Angeles, California, United States
- University of Kentucky Lexington, Kentucky, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT04684225
- Conditions
- Connective Tissue Diseases, Hand Rheumatism, Physiotherapy, +7 more
- Locations
-
- Tugba Civi Karaaslan Istanbul, Buyukcekmece, Cerrahpasa Medical Faculty, Turkey (Türkiye)
Completed
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
NCT01086540
- Conditions
- Autoimmune Diseases, Connective Tissue Diseases, Hypertension, Pulmonary, +8 more
- Locations
-
- Stanford Health Care Stanford, California, United States
- University of Colorado Health Sciences Center Aurora, Colorado, United States
- University of Iowa Iowa City, Iowa, United States
- Johns Hopkins University, Pulmonary and Critical Care Medicine Baltimore, Maryland, United States
Completed
Is a History of Pre-eclampsia a Risk Factor for Vascular Phenotype in Women With Systemic Sclerosis?
NCT04363021
- Conditions
- Connective Tissue Diseases, Female Urogenital Diseases and Pregnancy Complications, Hypertension, Pregnancy-Induced, +9 more
- Locations
-
- CHU de Clermont-Ferrand Clermont-Ferrand, France
- CHU de Dijon Dijon, France
- CHU de Lille Lille, France
- CHU de Limoges Limoges, France
NCT04335279
- Conditions
- Anxiety Disorders, Behavior, COVID-19, +21 more
- Locations
-
- Sir Mortimer B. Davis Jewish General Hospital Montreal, Quebec, Canada
Completed
A Protocol Based Treatment for Early and Severe Systemic Sclerosis With (Anti-CD20), Rituximab
NCT00379431
- Conditions
- Connective Tissue Diseases, Early and Severe Systemic Sclerosis, Scleroderma, Systemic, +2 more
- Locations
-
- UCL St. Luc Brussel Brussels, Belgium
- UZ Brussel Brussels, Belgium
- University Hospital Ghent Ghent, Belgium
- UZ Gasthuisberg Leuven Leuven, Belgium
NCT04752397
- Conditions
- Connective Tissue Diseases, Eosinophilic Fasciitis, Graft vs Host Disease, +7 more
- Locations
-
- Charité-Universitätsmedizin Berlin Berlin, Germany
Completed
Analysis of the Distribution of Regulatory B Cells in Blood of Multiple Sclerosis Patients
NCT02789670
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Connective Tissue Diseases, +9 more
- Locations
-
- CHRU de Lille Lille, France
NCT04300426
- Conditions
- Connective Tissue Diseases, Scleroderma, Systemic, Skin Diseases, +2 more
- Locations
-
- Haukeland University Hospital Bergen, Norway
- Oslo University Hospital Oslo, Norway
- University hospital of North Norway Tromsø, Norway
- St. Olavs hospital, Trondheim university hospital Trondheim, Norway